.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Julphar
QuintilesIMS
Johnson and Johnson
Moodys
Medtronic
Fish and Richardson
Fuji
AstraZeneca
Chinese Patent Office

Generated: September 19, 2017

DrugPatentWatch Database Preview

Dyclonine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dyclonine hydrochloride and what is the scope of dyclonine hydrochloride freedom to operate?

Dyclonine hydrochloride
is the generic ingredient in one branded drug marketed by Astrazeneca and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for dyclonine hydrochloride.

Summary for Generic Name: dyclonine hydrochloride

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list4
Bulk Api Vendors: see list38
Clinical Trials: see list2,277
Patent Applications: see list787
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dyclonine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
DYCLONE
dyclonine hydrochloride
SOLUTION;TOPICAL009925-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Astrazeneca
DYCLONE
dyclonine hydrochloride
SOLUTION;TOPICAL009925-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
QuintilesIMS
Covington
Fish and Richardson
US Department of Justice
McKinsey
Deloitte
Farmers Insurance
Harvard Business School
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot